News for ImmunoCellular Therapeutics Ltd - Google Finance

IMMUNOCELLULAR THERAPEUTICS LTD : ImmunoCellular Therapeutics ...

Thu, 16 May 2013 10:07:09 GMT

IMMUNOCELLULAR THERAPEUTICS LTD : ImmunoCellular Therapeutics ...
4-traders (press release) - May 16, 2013

ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) announced that the US Patent and Trademark Office (USPTO) has issued a patent covering methods of use of interleukin 13-receptor alpha 2 protein (IL-13R?2) in cancer ...

IMMUNOCELLULAR THERAPEUTICS LTD : ImmunoCellular Therapeutics to ...

Wed, 01 May 2013 10:06:10 GMT

IMMUNOCELLULAR THERAPEUTICS LTD : ImmunoCellular Therapeutics to ...
4-traders (press release) - May 1, 2013

ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced that it plans to report first quarter 2013 financial results on Thursday, May 9, 2013.

PENNY STOCK PERFORMERS: ImmunoCellular Therapeutics, Ltd., American ...

Wed, 15 May 2013 20:23:45 GMT

PENNY STOCK PERFORMERS: ImmunoCellular Therapeutics, Ltd., American ...
SBWire (press release) - May 15, 2013

Huntington Beach, CA -- (SBWIRE) -- 05/15/2013 -- PSPicks.com provides its subscribers with a free newsletter that reports up to the minute information and exclusive charts on cheap, undervalued, hidden, and undiscovered stocks traded on the NASDAQ, ...

Biotech Rally Creates Fertile M&A Ground for Small Caps: OncoSec Medical Inc ...

Thu, 16 May 2013 14:15:17 GMT

Biotech Rally Creates Fertile M&A Ground for Small Caps: OncoSec Medical Inc ...
Market Playground - May 16, 2013

So, given this background I am intrigued by the future of OncoSec Medical Inc. (OTCMKTS:ONCS) and ImmunoCellular Therapeutics Ltd. (NYSEMKT:IMUC). Both of these firms are focused on cancer research that target boosting of the immune system as a ...

ImmunoCellular Therapeutics Q1 13 Earnings Conference Call At 5:00 PM ET

Thu, 09 May 2013 19:03:21 GMT

ImmunoCellular Therapeutics Q1 13 Earnings Conference Call At 5:00 PM ET
NASDAQ - May 9, 2013

(RTTNews.com) - ImmunoCellular Therapeutics, Ltd.( IMUC ) will host a conference call at 5:00 PM ETMay 9, 2013, to discuss its Q1 13 earnings results.

ImmunoCellular Therapeutics Ltd (IMUC) Posts Quarterly Earnings, Beats ...

Thu, 09 May 2013 23:15:39 GMT

ImmunoCellular Therapeutics Ltd (IMUC) Posts Quarterly Earnings, Beats ...
Zolmax - May 9, 2013

ImmunoCellular Therapeutics Ltd logo ImmunoCellular Therapeutics Ltd (NASDAQ: IMUC) announced its earnings results on Thursday.

Biotechnology Roundup - Aveo Pharmaceuticals Inc. (NASDAQ:AVEO), Onyx ...

Wed, 01 May 2013 13:00:11 GMT

Biotechnology Roundup - Aveo Pharmaceuticals Inc. (NASDAQ:AVEO), Onyx ...
SBWire (press release) - May 1, 2013

Stamford, CT -- (SBWIRE) -- 05/01/2013 -- Jet Life Penny Stocks provides investors with the Best penny stock alerts on a regular basis.

Top Losers in After-hours Today, May 13 - Markets & Trade

Mon, 13 May 2013 21:05:34 GMT

Top Losers in After-hours Today, May 13 - Markets & Trade
MarketsNTrade - May 13, 2013

ImmunoCellular Therapeutics Ltd. (OTC:IMUC) is currently trading at $2.41 down -3.6% in after-hours on 5200 shares traded. IMUC is trading -1.45% below its 50 day moving average and 2.79% above its 200 day moving average.

AFTER-HOURS Top Losers Today: Spirit Realty Capital, Cubic Corp, MoSys ... - Pentagon Post
TOP LOSERS After-Hours Today: Spirit Realty Capital, Cubic Corporation ... - FxPips.com (blog)

Do Hedge Funds and Insiders Love Geron Corporation (GERN)?

Thu, 25 Apr 2013 17:17:20 GMT

Do Hedge Funds and Insiders Love Geron Corporation (GERN)?
Insider Monkey (blog) - Apr 25, 2013

These stocks are ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), Targacept , Inc. (NASDAQ:TRGT), Pacific Biosciences of California (NASDAQ:PACB), Chelsea Therapeutics International Ltd.

Position Yourself for Big Returns in the Stem Cell Space: Jason Kolbert

Mon, 13 May 2013 13:10:29 GMT

Position Yourself for Big Returns in the Stem Cell Space: Jason Kolbert
Trefis - May 13, 2013

Let's discuss ImmunoCellular Therapeutics Ltd. (IMUC:OTCBB). This small company is one of my favorites. Its phase 2 trial in glioblastoma multiforme is now completely enrolled, and we're waiting for data.